Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | CES2 | O00748 | 3/20 | 0.51 |
| ▸ | CES1 | P23141 | 3/20 | 0.51 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | PTGES | O14684 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2946253 | 1.00 | RECQL (0.60) | RECQLLMNATDP1CES2CES1 | |
| SCHEMBL2941701 | 0.98 | TDP1 (0.60) | RECQLLMNATDP1CES2CES1 | |
| SCHEMBL2941695 | 0.98 | TDP1 (0.60) | RECQLLMNATDP1CES2CES1 | |
| SCHEMBL1535093 | 0.97 | TDP1 (0.59) | RECQLLMNATDP1CES2CES1 | |
| SCHEMBL1375933 | 0.95 | RECQL (0.62) | RECQLLMNATDP1CES2CES1 | |
| SCHEMBL2941326 | 0.95 | RECQL (0.62) | RECQLLMNATDP1CES2CES1 | |
| Bicarbonate SCHEMBL8518325 | 0.93 | RECQL (0.60) | RECQLLMNATDP1CES2CES1 | |
| Oxalic Acid SCHEMBL10792364 | 0.92 | RECQL (0.58) | RECQLLMNATDP1CES2CES1 | |
| SCHEMBL17629136 | 0.88 | LMNA (0.66) | RECQLLMNATDP1CES2CES1 | |
| SCHEMBL17629135 | 0.88 | LMNA (0.66) | RECQLLMNATDP1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100111888-A1 | Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions | GIVAUDAN SA (CH) | 2010-05-06 | — | — | US | claimed |
| EP-2152658-A2 | ORGANIC COMPOUNDS AND COMPOSITIONS HAVING THE ABILITY TO MODULATE FRAGRANCE COMPOSITIONS | Givaudan SA (CH) | 2010-02-17 | — | — | EP | claimed |
| WO-2008116338-A2 | ORGANIC COMPOUNDS AND COMPOSITIONS HAVING THE ABILITY TO MODULATE FRAGRANCE COMPOSITIONS | GIVAUDAN SA (CH) | 2008-10-02 | — | — | WO | claimed |
| US-20180042229-A1 | DEUTERIUM-ENRICHED ALDEHYDES | DEUTERIA AGROCHEMICALS, LLC | 2018-02-15 | — | — | US | disclosed |
| US-9713330-B1 | Deuterium-enriched aldehydes | DEUTERIA AGROCHEMICALS, LLC (US) | 2017-07-25 | — | — | US | disclosed |
| US-9179670-B2 | Deuterium-enriched aldehydes | DEUTERIA AGROCHEMICALS, LLC (US) | 2015-11-10 | — | — | US | disclosed |
| US-20150208651-A1 | DEUTERIUM-ENRICHED ALDEHYDES | DEUTERIA AGROCHEMICALS, LLC | 2015-07-30 | — | — | US | disclosed |
| US-9023336-B2 | Deuterium-enriched aldehydes | Deuterra Agrochemicals, LLC (US) | 2015-05-05 | — | — | US | disclosed |
| US-20140271537-A1 | DEUTERIUM-ENRICHED ALDEHYDES | DEUTERIA AGROCHEMICALS, LLC | 2014-09-18 | — | — | US | disclosed |
| US-20100111888-A1 | Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions | GIVAUDAN SA (CH) | 2010-05-06 | — | — | US | disclosed |
| US-20100113460-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2010-05-06 | — | — | US | disclosed |
| US-20100111888-A1 | Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions | GIVAUDAN SA (CH) | 2010-05-06 | — | — | US | disclosed |
| US-20100111888-A1 | Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions | GIVAUDAN SA (CH) | 2010-05-06 | — | — | US | disclosed |
| US-20100113460-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2010-05-06 | — | — | US | disclosed |
| EP-2152658-A2 | ORGANIC COMPOUNDS AND COMPOSITIONS HAVING THE ABILITY TO MODULATE FRAGRANCE COMPOSITIONS | Givaudan SA (CH) | 2010-02-17 | — | — | EP | disclosed |
| EP-2139354-A2 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008116339-A2 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008116339-A2 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008116338-A2 | ORGANIC COMPOUNDS AND COMPOSITIONS HAVING THE ABILITY TO MODULATE FRAGRANCE COMPOSITIONS | GIVAUDAN SA (CH) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008116338-A2 | ORGANIC COMPOUNDS AND COMPOSITIONS HAVING THE ABILITY TO MODULATE FRAGRANCE COMPOSITIONS | GIVAUDAN SA (CH) | 2008-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150208651-A1 | DEUTERIUM-ENRICHED ALDEHYDES | XDH, ALDH5A1, AOX1 | RECQL 758/4885LMNA 1708/4885TDP1 965/4885 |
| US-20100113460-A1 | Organic Compounds | CYP2B6, CYP2A6, CYP2A13 | RECQL 2045/4885LMNA 4205/4885TDP1 1152/4885 |
| US-20140271537-A1 | DEUTERIUM-ENRICHED ALDEHYDES | XDH, ALDH5A1, AOX1 | RECQL 758/4885LMNA 1708/4885TDP1 965/4885 |
| US-20180042229-A1 | DEUTERIUM-ENRICHED ALDEHYDES | XDH, ALDH5A1, AOX1 | RECQL 758/4885LMNA 1708/4885TDP1 965/4885 |
| US-20100111888-A1 | Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions | CYP2A13, CYP1A1, CYP1B1 | RECQL 3116/4885LMNA 3819/4885TDP1 2721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.